Webinar Overview
The importance of human HEK293 cells has risen with its ability to produce many viral vectors for cell and gene therapy (CGT) products that Chinese hamster ovary (CHO) cells cannot. As CGTs continue to go into development and reach the market, there will naturally be an increase in HEK293 cell bank manufacturing.
Whether you’re in the early stages or near commercialization, it’s important to understand HEK293 cells’ potential for CGTs and what you need to consider when banking them.
In this webinar you'll learn:
- The range of HEK293’s cell banking applications
- Why HEK293 cells are important for viral vector production for cell and gene therapy products
- What manufacturing and viral safety testing you should consider to meet regulatory guidelines
Webinar Presenters
Nicole Posey, BS
Associate Director, Manufacturing Services
Charles River
Kerstin Brack, PhD
Scientific Director
Charles River